Nebenwirkungen · Renvela
Renvela 800 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 6
HOS-210010 · Präparat HOS-154423
Adverse reactions that occurred during clinical trials or that were spontaneously reported from post- marketing experience are listed by frequency in the table below. The reporting rate is classified as very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000), not known (cannot be estimated from the available data).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-01-08T14:14:00Z · SHA-256 bbf3dc33189cc1d9b3899a8467b5fba24bbecb6d3eee0294a19e6353e199788f · Passage ec7542025319ead6bff4f5d61581b9713b56a56dcdb601cc9c81af961e9aa953 · Zeichen 841–1231 im Abschnitt